LAS VEGAS, September 20, 2021 / PRNewswire / – Alkame Holdings, Inc. (OTC PINK: ALKM), a diversified holding company, is pleased to announce that its wholly owned subsidiary, Bell Food & Beverage Inc., has received a purchase order of Kona Gold LLC., a wholly owned subsidiary of Kona Gold Beverage Inc., to produce and bottle the company’s popular HighDrate CBD-infused energy water.
The order form of 125K of the product requires the production of 6 flavors of premium CBD infused energy water using Alkame’s proprietary technology. Alkame’s advanced water treatment technology creates premium alkaline oxygenated water infused with electrolytes and minerals for well-balanced hydration, with micro-clustering for increased bioavailability.
“We are very happy to continue the production of Highdrate with Kona Gold“said the CEO of Alkame Robert eakle.
About Alkame Holdings, Inc.
Alkame Holdings, Inc. is a publicly traded health and wellness technology holding company focused on patentable, innovative and environmentally friendly consumer products. The Company’s wholly owned subsidiaries manufacture products with improved water using proprietary technology to create products with several unique properties. The organization is diligently building a solid foundation through launching and acquiring suitable business assets, and pursuing multiple applications by positioning itself in several emerging business sectors, such as consumer bottled water and products. RTD, household pet products, horticultural and agricultural applications, hand sanitizers and many other water-based treatment solutions to new and existing business platforms.
For more information visit www.alkameholdingsinc.com.
Alkame Holdings, Inc. Investor Relations
E-mail: [email protected]
Safe Harbor / Disclaimer: This press release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that Alkame will achieve significant sales, non-compliance with the timetable or performance requirements of the Company’s contracts, the Company’s liquidity situation, the Company’s ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive prices. In light of these uncertainties, the forward-looking events mentioned in this press release may not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
THE SOURCE: Alkame Holdings, Inc.
SOURCE Alkame Holdings, Inc.